The aim of the present study was to investigate the inhibitory effects of a CX3CR1 small molecule antagonist (KAND567, previously named AZD8797) on the interaction between CLL cells and the TME by co-culturing autologous monocytes with CLL cells [17]. The gene discussed is CX3CR1; the disease is B-cell chronic lymphocytic leukemia.